Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:10 PM
Study NCT ID:
NCT01234558
Status:
COMPLETED
Last Update Posted:
2012-09-12
First Post:
2010-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Sponsor:
Naurex, Inc, an affiliate of Allergan plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-07
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-03
First Submit QC Date:
None
Study First Post Date:
2010-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-09-10
Last Update Post Date:
2012-09-12
Last Update Post Date Type:
ESTIMATED